We are live on ! Find out more
BLACU

Bellevue Life Sciences Acquisition Corp. Unit

Delisted

BLACU was delisted on the 14th of February, 2025.

2 hedge funds and large institutions have $1.17K invested in Bellevue Life Sciences Acquisition Corp. Unit in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less funds holding

Funds holding: 102 (-8)

100% less capital invested

Capital invested by funds: $7.63M → $1.17K (-$7.63M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-8
Holders Change %
-80%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CS
1
Clear Street
New York
$1.06K -$62.6K -5,901 -98%
TRCT
2
Tower Research Capital (TRC)
New York
$106
HIM
3
HGC Investment Management
Ontario, Canada
-$3.2M -300,000 Closed
Walleye Capital
4
Walleye Capital
New York
-$1.8M -168,128 Closed
Walleye Trading
5
Walleye Trading
New York
-$1.01M -94,572 Closed
SIA
6
Schechter Investment Advisors
Michigan
-$559K -52,850 Closed
SIA
7
SkyView Investment Advisors
New Jersey
-$323K -30,000 Closed
WC
8
Wealthspring Capital
New York
-$239K -22,550 Closed
CCM
9
Condor Capital Management
New Jersey
-$112K -10,600 Closed

BLACU Hedge Fund Activity: Q4 2023 in Review

2 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q4 2023, worth a combined $1.17K — down 100% from $7.63M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BLACU and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was HGC Investment Management, exiting entirely with an estimated $3.2M sold.

  • 2 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q4 2023, down from 10 in Q3 2023.
  • Funds reported $1.17K of Bellevue Life Sciences Acquisition Corp. Unit stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q4 2023 and 7 closed out, a net change of -7 holders.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit seller in Q4 2023 was HGC Investment Management, an estimated $3.2M sold.

Based on aggregated 13F filings for Q4 2023.